New Information about Surgical Mitral Valve Repair in Primary Mitral Regurgitation

New Information about Surgical Mitral Valve Repair in Primary Mitral Regurgitation

Ani Anyanwu, MD, and Randy Martin, MD, discuss recent findings about the safety and morbidity findings in over 53,000 patients who underwent surgical mitral valve repair for primary regurgitation over a 6-year period. This information was published in JACC by Dr. Vinay Badhwar. Dr. Anyanwu and Dr. David Adams at Mount Sinai’s Mitral Valve Repair Reference Center have had extensive experience over decades in surgical repair of primary mitral regurgitation.

Dr. Anyanwu highlights that low 30-day mortality and morbidity, while encouraging, is not a surrogate for quality. He and Dr. Adams feel the quality metrics should be based on procedural success at 30 days, procedural effectiveness at 1 year and durability over 5 years. Dr. Anyanwu also emphasizes the importance of eliminating MR at the initial operative intervention as well as paying attention to treating atrial fibrillation and coexistent tricuspid regurgitation.


Published

January 23, 2024

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

Anelechi Anyanwu, FRSC, MD

Anelechi Anyanwu, FRSC, MD

Professor and Vice Chair of the Department of Cardiovascular Surgery at the Icahn School of Medicine of Mount Sinai

View full profile

Randolph P. Martin, MD

Randolph P. Martin, MD

Clinical Professor, Department of Cardiovascular Surgery
Icahn School of Medicine at Mount Sinai